Logo

Epigenomics

Epigenomics Announces Layoffs, Product Line Cancellation in Restructuring

The firm is halting sale of Epi proColon and recalling the product as well as reducing its employee headcount after failing to raise additional capital.

People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Jan. 23, 2023.

In Brief This Week: Yourgene, Centogene, Epigenomics, AnPac Bio-Medical, Biodesix, SomaLogic

News items for the week of Dec. 19, 2022.

ClearNote Health Furthers Commercialization Prospects for Pancreatic, Ovarian Cancer Tests
Premium

The firm has commercialized its pancreatic cancer test and has its sights set on an ovarian cancer test launching in 2023. 

Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients

The firm will evaluate its epigenomic liquid biopsy test to detect pancreatic cancer among patients considered high-risk for the disease due to their diabetes.

Dec 2, 2022

Stanford Method Enables Targeted Profiling of Human Extrachromosomal DNA
Premium

Nov 9, 2022

Earnings Roundup: OraSure Technologies, Standard BioTools, LumiraDx, More

Oct 7, 2022

Center for Multiomic Human Brain Atlas to Tackle Methylation, Gene Expression for $500M NIH Project
Premium

Sep 19, 2022

Epigenomics Expecting Lower Loss in 2022 as It Launches Liquid Biopsy Study

Aug 10, 2022

Earnings Roundup: DermTech, 908 Devices, OraSure, Codex DNA, Aspira, IsoPlexis, Epigenomics

Jul 28, 2022

NYGC, Karolinska Institute Teams Develop Single-Cell, Multimodal Chromatin Profiling Assays
Premium

May 11, 2022

Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results

Mar 24, 2022

Epigenomics Posts Strong Revenue Gains in 2021 on Blood Biobank Sale

Dec 17, 2021

People in the News: New Appointments at Myriad Genetics, NeoGenomics, Epigenomics, More

Nov 19, 2021

People in the News: New Appointments at Rebus Biosystems, Jumpcode Genomics, Epigenomics, More

Nov 12, 2021

In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More

Aug 11, 2021

Epigenomics H1 Revenues Down 31 Percent

Mar 25, 2021

Epigenomics Reports 24 Percent Drop in 2020 Revenues, Seeks Sale After Negative Coverage Decision

Jan 20, 2021

CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon

Jan 7, 2021

Epigenomics Issues €5.5M Convertible Bond

Nov 12, 2020

Epigenomics Posts 30 Percent Rise in Q3 Revenues

Aug 13, 2020

Epigenomics Q2 Revenues Slide 76 Percent on Coronavirus Challenges

May 7, 2020

Epigenomics Q1 Revenues Down 28 Percent

Apr 29, 2020

Epigenomics Preliminary Q1 Revenues Drop 33 Percent

Feb 29, 2020

CMS Seeks Public Input on Epigenomics' National Coverage Request for Colon Cancer Screening Test

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.